Mårten Fernö
201 – 210 of 255
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1998
-
Mark
Urokinase plasminogen activator and flow cytometric S-phase fraction as prognostic indicators in breast cancer
(
- Contribution to journal › Published meeting abstract
- 1997
-
Mark
Flow cytometric S-phase fraction in soft-tissue sarcoma: prognostic importance analysed in 160 patients
(
- Contribution to journal › Article
-
Mark
Intra- and inter-laboratory reproducibility of estrogen and progesterone receptor enzyme immunoassay in breast cancer cytosol samples--a Swedish multicenter study. Swedish Society of Cancer Study Group
(
- Contribution to journal › Article
-
Mark
Prognostic implications of cytogenetic findings in kidney cancer
(
- Contribution to journal › Article
- 1996
-
Mark
Uterus and endometrium: Flow cytometric DNA analysis in endometriotic tissue compared to normal uterine endometrium
(
- Contribution to journal › Article
-
Mark
Urokinase plasminogen activator, a strong independent prognostic factor in breast cancer, analysed in steroid receptor cytosols with a luminometric immunoassay
(
- Contribution to journal › Article
-
Mark
Methodological aspects of flow cytometry DNA analysis in endometrial carcinoma, with special reference to sampling and reproducibility
(
- Contribution to journal › Article
-
Mark
Preoperative fine needle aspiration from human breast cancer is a valuable sampling material for progesterone receptor and cytometric DNA analysis
(
- Contribution to journal › Article
-
Mark
Urokinase-plasminogen-activator levels and prognosis in 69 soft-tissue sarcomas
(
- Contribution to journal › Article
- 1995
-
Mark
Recurrence-free survival in breast cancer improved by adjuvant tamoxifen--especially for progesterone receptor positive tumors with a high proliferation
(
- Contribution to journal › Article